Tamuzimod in Patients with Moderately-to-severely Active Ulcerative Colitis: a Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Induction Trial
The Lancet Gastroenterology & Hepatology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined